Current Liabilities
Lease Liability Payments - Due Year Three
Neurocrine Biosciences Lease Liability Payments - Due Year Three decreased by 0.7% to $59.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.5%, from $60.70M to $59.80M. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ2 2020
Last reportedQ1 2026May 5, 2026
How to read this metric
Helps assess the company's long-term fixed obligation profile and future cash flow requirements.
Detailed definition
The projected cash payments for operating and finance leases scheduled for the third year following the balance sheet da...
Peer comparison
Standard disclosure for lease maturity profiles.
Metric ID:
lease_liability_payments_due_year_3Historical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $17.00M | $17.00M | $15.90M | $15.90M | $15.90M | $15.70M | $15.70M | $15.70M | $34.80M | $35.80M | $35.80M | $60.70M | $60.70M | $60.20M | $59.80M |
| QoQ Change | — | +0.0% | -6.5% | +0.0% | +0.0% | -1.3% | +0.0% | +0.0% | +121.7% | +2.9% | +0.0% | +69.6% | +0.0% | -0.8% | -0.7% |
| YoY Change | — | — | — | -6.5% | -6.5% | -1.3% | -1.3% | -1.3% | +121.7% | +128.0% | +128.0% | +74.4% | +69.6% | +68.2% | -1.5% |
Range$15.70M – $60.70M
CAGR+43.2%
Avg YoY Growth+47.6%
Median YoY Growth+33.4%
Current Streak2 quarters decline
Lease Liability Payments - Due Year Three at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's lease liability payments - due year three?
- Neurocrine Biosciences (NBIX) reported lease liability payments - due year three of $59.80M in Q1 2026.
- How has Neurocrine Biosciences's lease liability payments - due year three changed year-over-year?
- Neurocrine Biosciences's lease liability payments - due year three decreased by 1.5% year-over-year, from $60.70M to $59.80M.
- What does lease liability payments - due year three mean?
- The total lease payments due in the third year from now.